A Phase 1b Open-Label Non-Randomızed Study To Assess The Safety, Pharmacokınetıcs, And Pharmacodynamıcs Of Marstacımab Treatment Followıng The Dıscontınuatıon Of Emıcızumab Therapy In Adolescent And Adult Partıcıpants Wıth Severe Hemophılıa A Wıthout Inhıbıtors (B7841014)